Adjuvants: current status, clinical perspectives and future prospects
- 31 May 1993
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 14 (5) , 174-178
- https://doi.org/10.1016/0165-6147(93)90204-w
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Human TH1 and TH2 subsets: doubt no morePublished by Elsevier ,2004
- The immune system evolved to discriminate infectious nonself from noninfectious selfPublished by Elsevier ,2003
- The iscom structure as an immune-enhancing moiety: experience with viral systemsResearch in Immunology, 1992
- SaponinResearch in Immunology, 1992
- Non-ionic block polymer surfactants as immunological adjuvantsResearch in Immunology, 1992
- The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virusArchiv für die gesamte Virusforschung, 1992
- ISCOMS — a novel strategy for mucosal immunization?Immunology Today, 1991
- Quaternary structure of the immunostimulating complex (Iscom)Journal of Ultrastructure and Molecular Structure Research, 1989
- Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populationsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974